“…It has been reported that the tricyclic antidepressant drug, desipramine, blocks the uptake of tyramine into sympathetically innervated tissues (Brodie, Costa, Groppetti & Matsumoto, 1970) and thus antagonizes pharmacological responses to tyramine (Gessa, Vargin & Crabai, 1966;Fozard & Mwaluko, 1976). However, desipramine can also block the uptake of NA (Hertting, Axelrod & Whitby, 1961;Iversen, 1965) which may result in potentiation of the responses to NA (Sigg, Soffer & Gyermek, 1963;Sturman, 1970;McCulloch & Story, 1972). Thus desipramine and other uptake-blocking tricyclic antidepressants (e.g.…”